Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-05

Clinical Trial Update: Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine [Phase 3]

View source ↗

Summary

Phase 3 trial comparing maraviroc plus zidovudine/lamivudine versus efavirenz plus zidovudine/lamivudine in HIV-1 infection. Results completed and posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epivir (Lamivudine)
  • RETROVIR (Zidovudine)
  • Selzentry (Maraviroc)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV-1 | Phase 3 | Status: COMPLETED | Results posted: 2012-10-05